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ABSTRACT
Research on anti-mycobacterial bioactivity of lectin protein from red algae Gelidium 
amansii of Barang Lompo Island was conducted. Pre-purification of protein using fractional 
method, showed bioactivity  against Mycobacterium tuberculosis  in whole extract and with the 
saturation level of ammonium sulfate of 40-60%. Further purification of this protein fraction 
using column chromatography system followed by protein sequencing, indicated the pure protein 
as lectin, that migrates as a single-band on SDS-PAGE with molecular weight of 21 kDa. Based 
on amino acids partial sequence, we cloned and sequenced cDNA encoding lectin protein.  It 
consists of 552 nucleotides encoding 183 amino acid residues including a putative initiation Met. 
To obtain it in large amounts, the coding sequence of lectin  was cloned into pGEX-2TK vector 
and expresed as a lectin fusion protein in Escherichia coli. Recombinant lectin protein alone did 
not show any growth inhibitory effect on M. tuberculosis, but could  increase the sensitivity of 
this pathogen to drug streptomycin. These research suggests that anti-mycobacterial lectin 
protein in combination with  streptomycin  may play an important role in host defence against 
M. tuberculosis strain H37Rv.
Keywords: Red algae, Gelidium amansii, Lectin, Recombinant protein, Anti-mycobacterial
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INTRODUCTION
Indonesia, a maritime country with ocean area of 75% covering the country, has abundant 
source of marine biota; among them are a variety of marine algae  species. Some species have 
been reported to contain bioactive compounds with wide applications in the pharmaceutical 
industries (Sheih et al. 2010). In parallel to the trend of disease pattern changes such as the 
resistance of  disease germs towards a certain medicine, efforts to find new medicines are 
necessarily to be carried out. Until recently, marine natural resources have not been optimally 
utilized. Therefore, any efforts to identify potential bioactive compounds from marine natural 
resources will be of great interest (Blunt et al. 2007).
2On the other hand, worldwide, tuberculosis (TB) remains the most frequent and important 
infectious disease causing morbidity and death. One-third of the world's population is infected 
with Mycobacterium tuberculosis (MTB), the etiologic agent of TB. The World Health 
Organization (WHO) estimates that about eight to ten million new TB cases occur annually 
worldwide and the incidence of TB is currently increasing (WHO. 2005). In this context, TB is 
in the top three, with malaria and HIV being the leading causes of death from a single infectious 
agent, and approximately two million deaths are attributable to TB annually. In particular, 
pulmonary TB, the most common form of TB, is a highly contagious and life-threatening 
infection. Moreover, enhanced susceptibility to TB in HIV-infected populations is another 
serious health problem throughout the world. In addition, multidrug-resistant TB (MDR-TB) has 
been increasing in incidence in many areas, not only in developing countries but also 
industrialized countries as well, during the past decade, including in Indonesia (WHO. 2005). 
Very recently, patterns of resistance to commonly used anti-tuberculosis drugs among M. 
tuberculosis complex isolates from patients attending government urban TB diagnostic in 
Makassar, the capital of the South Sulawesi Province in Indonesia, was found the highly 
potential risk factors for MDR-TB (Massi et al. 2011). In order to tackle these new situations, it 
is necessary and important to develop not only new treatment guidelines, but also new anti-
mycobacterial drugs for efficacious clinical control of TB patients. 
Protein as anti-mycobacterial medicine has been promising since it can be well accepted 
by human body and has few side effects. Therefore, research on the use of protein and or 
peptides as a source of medicine is tremendously growing. Moreover, the genes in a group of 
protein can be cloned to produce medicine in large scale using genetic engineering approach.
Antimicrobial protein/peptides (APs) from eukaryotes are components of the innate immune 
defense and display potent antimicrobial activity against a variety of microorganisms (Liao et al.
2003). Lectins are proteinaceous substances that are widely distributed in animals, plants, and 
microorganisms have been found to contain hemagglutinating activity (Etzler 1986). Since the 
report of Boyd et al. (1966), numerous studies have indicated that marine algae contain lectins 
capable of binding specific carbohydrates to produce unique biological activities, such as the 
aggregation of erythrocytes, yeasts, bacteria, and various unicellular algae (Hori et. al. 1986;
Hori et. al. 2007). In marine algae, lectins play an important role in recognition and adherence of 
gametes during sexual reproduction (Kim and Kim 1999). Marine organism lectins including 
from algae seem to be especially interesting for biological applications, because they are in small 
molecules, induce minor immunogenicity in host cells, possess great stability on account of their 
several disulfide bridges, and show high specificity for complex glycoconjugates, such as the 
3ones present on cell surfaces (Sampaio et al. 1998). Other biological and ecological activities of 
algae lectins are probably involved in symbiosis and defense as exhibited by lectins of terrestrial
plants (Etzler 1986), and other marine invertebrates (Kilpatrick 2002; Olafsen 1996). However, 
these results have not been clearly proven. APs appear to interact and cross cell envelope 
membranes of microbes and kill cells by a complex mechanism that involves action on more 
than one anionic target. Antimicrobial protein/peptides lectin, protegrin-1, human alpha-
defensin-1, and PR-39 are known to be active against vibrios and mycobacterium (Liao et al.
2003; Fattorini et al. 2004; Linde et al. 2001), the organism responsible for tuberculosis, but no 
studies on the combination between APs and clinical anti-MTB drugs have been performed. 
Thus, purification and characterization of lectins from a variety of plant and animal 
species interests researchers in the field of biochemistry and molecular biology. The more that is 
known about the lectins, the wider are the applications of this type of proteins. In this study, we 
report for the first time the purification, characterization, and cDNA cloning of a new anti-
mycobacterial lectin protein isolated from red algae of Gelidium amansii. Next we tested the 
activity of lectin recombinant protein alone and in combination with the anti-MTB drug 
streptomycin (SM), against Mycobacterium tuberculosis (MTB) strain H37Rv (ATCC 27294) to 
increase  sensitivity of anti-mycobacterial drugs.
MATERIALS AND METHODS
Materials
Red algae Gelidium amansii was collected in the region of Barang Lompo Island, South 
Sulawesi Province, Indonesian territory. pGEX-2TK vector, CM-cellulose, Sephadex G-100, E. 
coli BL21 competent cells, glutathione agarose beads, and Trizol  reagent kit were purchased 
from Amersham Pharmacia Biotech. Mono S resin was purchased from GE Healthcare (Hong 
Kong). Streptomycin, INH, ammonium sulphate, and lysozyme were purchased from Sigma.
Procedures
Isolation and purification of anti-mycobacterial  lectin protein from red algae
Five hundred grams of fresh red algae Gelidium amansii were homogenized with waring 
blender using 500 mL of buffer solution A (Tris-HCl 0,02 M pH 7,3, NaCl 0.2 M, CaCl2 0,01 M, 
 -mercaptoetanol 1 %, Triton X- 100 0,5 %). Next, resultant was filtered with Buchner. The 
filtrate obtained was frozen and re
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mycobacterial agent and further purification steps. 
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61X PBS buffer. The fusion protein (GST-Lectin) was eluted with 4 mL of 20 mM glutathione in 
20 mM Tris-HCl, pH 7.3, and the resultant eluate was concentrated with a Millipore membrane, 
followed by the addition of glycerol to a final concentration of 20%. The samples obtained were 
resolved by 14% SDS-PAGE, according to Sambrook et al., (1989). The recombinant GST-lectin 
fusion protein concentrations were determined by the Lowry method  (Lowry et al. 1955) using 
BSA as a standard. The anti-mycobacterial activity of the recombinant GST-lectin fusion protein 
was determined as described below.
Anti-mycobacterial  activity assays
For the initial screening, standard colony assays on Löwenstein-Jensen (LJ) medium were 
performed to assess the anti-mycobacterial activity of whole extract, ammonium sulphate 
fraction, native and recombinant lectin protein with the final concentrations of 10 g/mL, 
respectively, using the strain M. tuberculosis H37Rv (ATCC 27294) and solvent 0.02 M Tris-
HCl pH 7.3 as negative control and combination of streptomycin plus INH as positive control 
(Yu et al. 2011).  For testing the anti-mycobacterial activity of recombinant lectin protein and in 
combination with streptomycin, the strain M. tuberculosis H37Rv (ATCC 27294) were grown on 
Middlebrook 7H10-OADC (oleic acid, albumin, dextrose, catalase) (Difco Laboratories) at 37 °C 
for 3 weeks until midlog phase. Tenfold serial dilution (20 L in 10-1, 10-2, 10-3, and 10-4) were 
streaked on Middlebrook 7H10-OADC agar plate containing solvent (0.02 M Tris-HCl pH 7.3) 
as negative control, streptomycin (5 and 10 g/mL), and recombinant lectin  and or native lectin 
(5 and 10 g/mL) were indicated. Plates were incubated at 37 °C and inhibition growth were 
documented after 2 to 3 weeks. The assays was conducted in duplicates and repeated three times 
to produce representative experimental data.
RESULTS AND DISCUSSION 
Results
Isolation, pre-purification, and determination of lectin protein concentration 
   The whole extract having anti-mycobacterial activity was fractionated using 
ammonium sulphate at the saturation level of 0 – 20%, 20 – 40%, 40 – 60%, and 60 – 80%.  The 
addition of ammonium sulphate salts from low to high concentration resulted  in different protein 
types precipitated. Higher concentration of ammonium sulphate caused a lot of hydrophobic 
functional groups neutralized by ammonium sulphate salts so that water could no longer bond 
7resulting in the decrement of protein solubility in water causing the protein to be precipitated.  
Data on distribution pattern of whole extract and protein fraction at fractionation of various 
saturation levels of ammonium sulphate is shown in Table 1. Protein concentration from whole
extract of red algae Gelidium amansii was 1.2 mg/mL with the total amount of protein 492.0 mg 
from the whole extract volume 410 mL. The highest protein concentration of 5.6 mg/mL was 
found at fraction of ammonium sulphate 40-60%, whereas the lowest protein concentration (1.5
mg/mL) was found at ammonium sulphate fraction 60-80%.
Table 1. Distribution of protein concentration in whole extract  and protein fraction at fractionation of 
various saturation levels of ammonium sulphate from red algae Gelidium amansii
No. Protein Fractions Fraction Volume 
(mL)
Protein Concentration
(mg/mL)
Total Protein 
(mg)
1 Whole extract 410 1.2 492.0
2 0-20 % 25.0 4.5 112.5
3 20-40 % 25.0 1.6   40.0
4 40-60 % 25.0 5.6 140.0
5 60-80 % 25.0 1.5   37.5
Screening of  native  anti-mycobacterial lectin protein
At the first experiment of anti-mycobacterial test, it was obvious that each protein 
fraction from red algae Gelidium amansii at various levels of saturated ammonium sulphate 
exhibited anti-mycobacterial activity as indicated by 40-60% fraction protein, and whole extract
samples with no colony growth  of M. tuberculosis on Löwenstein-Jensen medium. However,
other fractions did not display anti-mycobacterial activity (Figure 1). This finding was in 
accordance with previous study that antibacterial and antitumor protein from marine algae was 
found from 40-60% fraction level of saturated ammonium sulphate (Liao et al. 2003; Yan, et al.
2009).  Hence, these fractions were very promising and were selected for further efforts on 
purification and cloning of the gene encoding  lectin protein compound for future experiment.
8Figure 1. The colony growth of M. tuberculosis on Löwenstein-Jensen medium containing protein from 
red algae Gelidium amansii at various level of precentanges saturated of ammonium sulphate as indicated.
Purification of  native  anti-mycobacterial lectin protein from red algae Gelidium amansii
Protein fraction (100 mg) from ammonium sulphate fractionation at 40-60% fraction was
applied on a CM-cellulose cation-exchange column (5×18 cm). Proteins bound to the CM were 
eluted using a gradient from 0.1 to 0.5 M Tris-HCl pH 7.3 at a flow rate of 1 mL/min, and 60 
fractions were collected. The fractions eluting between tube number 24 to 28 demonstrated 
hemagglutinating activity (Figure 2A). Next, the protein fraction from CM-sellulose cation-
exchange column that demonstrated hemagglutinating activity were applied to gel filtration  
chromatography on Sephadex-G100, and the resulting three peaks were collected. The first and 
third peaks showed no hemagglutinating activity, while the second peak indicated having 
hemagglutinating activity (Figure 2B). The second peak was further purified by FPLC on Mono 
S column using a shallower acetonitrile gradient, giving the single peak of pure protein (Figure 
2C). Based on the SDS-PAGE (14%), the molecular weight of the purified lectin protein was 
estimated to be approximately 21 kDa (Figure 2D),  and this result was consistent with that
calculated by Bioedit 7.9 software, giving the molecular weight of 20,822 Da (result not shown).
9Figure 2. Purification of a novel anti-mycobacterial lectin protein from the red algae Gelidium amansii
(A) Cation-exchange chromatography of protein 40-60% fraction from ammonium sulphate fractionation 
on a CM-cellulose cation-exchange column (5×18 cm). (B) Gel filtration chromatography of pooled 
active fractions from the cation-exchange column on a Sephadex G-100 column (1.5 X 134 cm). (C) 
Pooled active fractions of peak two from gel filtration chromatography in (B) was purified by FPLC on 
mono S column using a shallower acetonitrile gradient. The elution profile was monitored at 280 nm. (D) 
SDS-PAGE (14%) analysis of the active fractions obtained at each purification step. The gel was stained 
with Coomassie Brilliant Blue R. Lane 1, Protein marker in kDa; lane 2, whole extract materials; lane 3, 
protein 40-60% fraction from ammonium sulphate fractionation; lane 4,  pooled active fractions from 
CM-Cellulose chromatography; lane 5, pooled active fractions (peak 2) from gel filtration 
chromatography; lane 6, single peak from the FPLC system. 
Amino acid sequencing and gene cloning encoding lectin protein
Enzymatic digests of native lectin protein with endoproteinase C were separated by RP-
HPLC and subjected to protein sequencing, resulting in the partial N-terminal and an internal 
fragment of amino acid sequence of lectin, identified to be sequence PLQGRSQKTE and 
GNEDCLDLRT, respectively. To complete the amino acid sequence of lectin, cDNA sequencing 
was carried out by RT-PCR and plaque hybridization. Based on the partial amino acid sequence 
above, the algae lectin specific probe of 422 bps (Figure 3 in lane 4) was identified with 
oligonucleotides corresponding to peptides derived from pure native lectin, using PCR and DNA 
sequence analysis. The probe was used to screen a whole extract cDNA library of red algae 
Gelidium amansii (about 200,000 recombinant phages), and one positive clone with the a largest 
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cDNA insert was chosen and subjected to restriction mapping followed by sequence 
determination. The nucleotide and deduced amino acid sequences are shown in Figure 4. The 
cDNA included 599 nucleotides with an encoding region of lectin protein  of 552 nucleotides.
The open reading frame for the cDNA encoded for a native protein of 183 amino acid residues 
with a molecular weight of 20,822 Da (as calculated  by Bioedit software) (result not shown). 
The candidate for an initiation codon atg was found at nucleotide position 21. The stop codon 
Figure 3. Schematic representation of the lectin gene synthesis by the RT-PCR and plaque 
hybridization method and the construction of pGEX-2TK fusion vector. A) Agarose gel electrophoresis 
of DNA fragment of RT-PCR product and recombinant plasmid. Lane 1, DNA lambda/HindIII marker; 
lane 2, two fragments DNA containing pGEX-2TK vector (4963 bps) and insert of Lectin DNA minus 5’ 
untranslation region (552 bps) digested by NdeI/EcoRI restriction enzymes of recombinant plasmid in B; 
lane 3, largest cDNA insert (599 bps) from positive clone; and lane 4, RT-PCR product of lectin DNA as 
probe (422 bps). B) Restriction map of pGEX-2TK lectin cDNA plasmid.
at position 550 was followed by polyadenylation signal  agaaaa, starting at position 569. Amino 
acid sequences of the isolated peptides derived from algae lectin corresponded exactly to the 
protein sequence deduced from the cDNA sequence, clearly indicating that the isolated cDNA 
clone codes for lectin protein. 
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Figure 4. The cDNA and deduced amino acid sequence of lectin protein. Fragment DNA  (422 bps) as 
probe synthesis by RT-PCR amplification of total red algae Gelidium amansii cDNAs was inserted into 
pGEX-2TK vector to yield pGEX-2TK Lectin recombinant plasmid. The nucleotide sequence was 
analyzed by the dideoxy chain-termination method. The result of N-terminal and an internal fragment of 
amino acid sequencing obtained from protein sequencing is indicated in box and the two primers L1 and 
L2 oligonucleotide were  obtained based partial amino acids sequencing is underlined. 
Based on Bioedit 7.9 software of the amino acids sequence, the sequence revealed  high 
homology with the Pm_lectin protein from crustacea (68%), but low homology with the 
Pp_lectin  protein  from mollusca (24%), and Aj_lectin  protein  from chordata (22%) (Figure 5). 
This results clearly indicated that the fragment DNA isolated from red algae Gelidium amansii
was a gene encoding lectin protein, and could be amplified using the generated primer pairs from 
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the partial amino acid sequence of native lectin protein. Therefore, future intensive research is 
required to trace the existence of this gene and its product, especially to determine another 
bioactivity to strengthen the structural and  functional analysis of lectin protein, since the lectin 
protein also possesses anticancer (Ahmad and Massi, 2011, in preparation) and antioxidants 
activity (Sheih et al. 2010).
Figure 5. Comparison of the aligned amino acid sequences of lectin of of red algae Gelidium amansii
(Ga_Lectin) with Crustacea Penaeus monodon (Pm_Lectin, Genebank DQ078266), Chordata Anguilla 
japonica (Aj_lectin, Genebank: AB060538),  and mollusca Pteria penguin (Pp_lectin, Genebank:
AB037167). The complete amino acid sequences of four proteins of marine organisms are shown. The 
positions of the amino acid sequence are indicated on the ends. Amino acid residues that are identical in 
two is marked with : and three is marked with . and analogous amino acids in all these proteins are 
indicated by bold letter.
Expression and purification of the recombinant lectin  protein in E. coli
The coding sequence of cDNA lectin was expressed as part of the pGEX-2T fusion 
protein, GST-lectin. The one-step purification procedure as described in (Ahmad et al. 1999) was 
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used to improve solubility of the GST-lectin fusion protein. Based on SDS–PAGE (14%) in 
Figure 6, the molecular mass of the GST-lectin fusion protein product was ≈ 47 kDa (fusion of 
the molecular mass of the lectin alone was ≈ 21 kDa with the GST was ≈  26 kDa) was 
dramatically accumulated in E.coli BL 21 cell containing the pGEX-2TK lectin plasmid with 
induction by 60 M IPTG and could be purified to more than 95% homogeneity, using 
glutathione agarose beads (see lane 3 in Figure 6). 
Figure 6. Electrophoresis SDS-PAGE (14%) analysis of the recombinant GST-lectin fusion protein and 
native lectin protein. Lane 1, Protein marker; Lane 2, Whole extract protein in E. coli cell containing 
pGEX-2TK lectin cDNA; Lane 3, Recombinant GST-lectin fusion protein; Lane 4, native lectin  protein 
and Lane 5, GST protein alone.
Anti-mycobacterial activity of the recombinant GST-lectin fusion protein
The anti-mycobacterial activity of the recombinant GST-lectin fusion protein against M. 
tuberculosis test was performed with LJ medium and Middlebrook 7H10-OADC agar plate 
assay. The combinations of recombinant lectin and streptomycin were tested in the anti-
mycobacterial assay described above by a checkerboard method in order to identify those 
combinations that could enhance bioactivity effect. The recombinant lectin alone was not able to 
exhibit bacterial growth, although native lectin protein contained anti-mycobacterial activity 
(Figure 7), and was in accordance with the results of the whole extract and protein fraction in 40-
60% saturation that showed significant inhibition of growth of M. tuberculosis (Figure 1). This 
difference in results might indicate  that whole extract and 40-60% fraction protein could contain  
other compound(s) that increase synergical effect on growth of M. tuberculosis and/or the 
recombinant lectin had structural differences in properties compared to native lectin or the 
incorrect folding of recombinant lectin protein. The combinations with the streptomycin was able 
to exhibit enhanced mycobacterial effect not only from native lectin but also recombinant lectin
14
at the lowest concentration (5 g/mL) of anti-mycobacterial agent (Figure 8). In conclusion, our 
results demonstrated that recombinant  lectin was active against M. tuberculosis when used in 
Figure 7. Effect of recombinant and native lectin protein alone on growth inhibition of M. tuberculosis
H37Rv (ATCC 27294) strain in Löwenstein-Jensen medium bottle. 
combination with other antimicrobial agents (streptomycin), and increased the sensitivity of the 
anti-TB drug. This result suggested a future use of the protein in association with clinically used 
drugs in TB therapy.
Figure 8. Effect of recombinant lectin protein (A) and native lectin protein (B) in combination with 
streptomycin in Middlebrook 7H10-OADC agar plate on growth inhibition of M. tuberculosis H37Rv 
(ATCC 27294) strain. Region a, b, c, and d correspond to serial dilution  (10-1, 10-2, 10-3, and 10-4) of an 
M. tuberculosis H37Rv settling culture (OD600= 0.2).
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DISCUSSION
In the current study, we purified and cloned a novel anti-mycobacterial lectin protein 
from a red algae Gelidium amansii of the class Rhodophyceae. Recently, Liao et al. (2003) found 
the strong antibiotic lectin from marine algae against vibrios. Further, Schröder et al. (2003) 
identified and cloned anti-bacterial lectin protein from sponge S. domuncula with activity 
against the gram-negative E. coli and the gram-positive S. aureus. Very recently British, Irish 
and Turkish seaweeds of several green, brown, and red algae were reported with anti-
mycobacterial effects (Allmendinger et al. 2010; Spavieri et al. 2010 Selçuk et al. 2011). A few 
of their genes encoding some proteins that function similarly to antibodies have been cloned, 
which is critical for further studies; however, no lectin gene or protein sequence was reported 
from tropical algae to date, especially from Indonesian territory. In this work, a novel anti-
mycobacterial lectin from red algae Gelidium amansii was characterized, its cDNA was cloned
and expressed in E. coli as recombinant protein. Our results indicated that lectin from red algae 
Gelidium amansii acts primarily on acid-fast bacteria especially against M. tuberculosis. This 
results was in accordance with previous study that hot water extracts from Gelidium capillaries 
and Gelidium amansii showed some inhibition towards M. avium and M. tuberculosis, 
respectively (Kamimoto,  1956).
Molecular structures and the aligned amino acid sequences of different lectins isolated 
from various crustaceans, chordate, mollusca, and marine algae are quite different. Most purified 
algae lectins are multimeric proteins, containing a unique subunit ranging from 20 to 40 kDa 
(Oliveira et al., 2002). We found red algae Gelidium amansii lectin to be a monomer with 
molecular weight of 21 kDa; however, its ability to function as an anti-mycobacterial agent 
suggested that it may be oligomeric and correct structure although it might not be covalent bond,
disulphide-bonded forms were seen on gels. In addition, we concluded that red algae Gelidium 
amansii lectin was not a glycoprotein on the basis of the results of various experiments and 
sequence analysis. Analysis of a recombinant product of lectin protein in E. coli showed no 
activity when tested alone; required glycosylation or the other post translational modification. 
Most lectins are glycoproteins, but the glycosyl in lectins may not be involved in carbohydrate 
recognition.
Individual animal species probably contain several lectins, including C-type lectins of 
different specificities, for detecting a variety of pathogens. Recognition of microorganisms by 
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these lectins may trigger different immune responses. Although multiple lectins have been 
isolated from some marine invertebrates, such as tunicates (Nair et al. 2000), sponges (Miarons
et al. 2000), crustaceans (Cominetti et al. 2002), echinoderms (Hatakeyama et al. 1994), and fish 
egg (Jimbo et al. 2007), no further study on its gene was published until now in marine algae, 
especially from Indonesian territory. Moreover, we have purified, cloned and identified an anti-
mycobacterial lectin gene from red algae Gelidium amansii in Barang Lompo Island, South 
Sulawesi Province, Indonesian territory and found that lectin protein contained direct or indirect 
anti-mycobacterial activity. The biological function of lectin protein in red algae Gelidium 
amansii itself is undiscovered, but this lectin plays some roles in the self-defence system of red 
algae Gelidium amansii. It should be noted that lectin protein from marine invertebrates 
interacted with not only Gram-negative but also Gram-positive bacteria (Schröder et al. 2003), 
including acid-fast bacteria. The bioactivity of lectin may appear to function as a pattern 
recognition protein specific for Gram-negative and acid-fast bacteria through its interaction with 
Lipopolysaccharide (LPS), and also as an opsonin to increase the efficiency of hemocyte 
phagocytosis. Lectin protein combined with LPS causes rapid agglutination of Gram-negative
and acid-fast bacteria, and lectin protein combined with phagocytes causes sensitization of the 
phagocytes to bacteria. 
We used in vitro systems in this study; further studies need to be performed regarding
anti-mycobacterial activity and repeated in an in vivo system. Therefore, it is necessary to carry 
out some more studies in animal models of tuberculosis to confirm these findings. These works 
might provide a significant foundation for further research on the anti-mycobacterial action in 
molecular and cellular level of lectin protein from marine algae and also it would be helpful to 
recognize lectin's role in the marine invertebrate innate immunity.
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